Introduction
inadequate nutrient intake, stress, and systemic illness, the pulsatile release of gonadotrophic hormones is dramatically impaired and can bring about hypogonad-A common problem that remains difficult to diagnose ism by suppression of GnRH pulse generator output. and treat in patients with chronic renal failure (CRF ) There is reduction in plasma testosterone and an is sexual dysfunction. Prevalence estimates of sexual dysfunction range from 9% in predialysis to 70% in increase in luteinizing hormone (LH ) and follicledialysis patients of either sex [1, 2] . The presence of stimulating hormone (FSH ) levels. The decrease in erectile dysfunction ranges between 21 and 43% among testosterone is attributed to a variety of mechanisms dialysis and transplant patients and this prevalence has including an elevated testosterone elimination profile, remained the same since the 1970s [3] . The causes of impaired Leydig cell production, and a reduction in erectile dysfunction are frequently combinations of the response to human chorionic gonadotrophin stimuboth organic and psychological factors. We review the lation [5] [6] [7] [8] . The low testosterone levels stimulates LH pathogenesis, investigations, and treatment currently secretion and plasma LH levels are further increased available for erectile dysfunction.
by the impairment in degradation in patients with ESRD. FSH levels are increased due to atrophy of the Sertoli cells which are normally responsible for its
Pathophysiology of erectile dysfunction
suppression by the secretion of the peptide inhibin [7] [8] [9] . Numerous sexual stimuli are processed by the brain Hyperprolactinaemia has been reported in 25-57% and transmitted to the penis by parasympathetic of male ESRD patients and has been implicated impulses that pass through the nervi erigentes to the in impotence, hypogonadism, and reduced desire. penis. This results in vasodilatation of the arteries, Hyperprolactinaemia interferes with gonadal responses relaxation of the smooth layer, and compression of the to gonadotrophins, resulting in a reduction in sexual veins against the rigid tunica albuginea, thus allowing steroid secretions. Interestingly, it is not clear from the blood to build up under high pressure in the erectile literature what the sexual effects of hyperprolactinaetissue of the penis. The vascular muscle in the spongy mia are and the underlying mechanism remains area becomes engorged with blood resulting in bal-obscure [10] . looning of the erectile tissue to such an extent that the Erectile dysfunction may be the earliest feature of penis becomes hard and elongated. diabetic autonomic neuropathy; however, uraemic men Erectile dysfunction is often the result of multi-without diabetes can also present with this complaint. system disease processes involving the hypothalamic-Tissue obtained from diabetic men with impotence pituitary-gonadal axis, vascular supply, and penile exhibits a functional impairment in the neurogenic and tissue damage from either infections or trauma. endothelium-mediated mechanisms that allow relaxaPsychological factors such as fatigue, stress, and tion of the smooth muscle of the corpus cavernosum depression may result from chronic illness and contrib- [11] . Precautious (premature) arteriosclerosis, includute further to the patient's loss of erection.
ing pelvic arteries and alteration of these relaxation End-stage renal disease ( ESRD) causes imbalance mechanisms, may explain the unusually high prevalin the hypothalamic-pituitary-gonadal axis in man, ence of impotence among men with diabetes mellitus, but it is not clear to what extent neurogenic factors intercourse questionnaire and nocturnal penile tumul-FSH, and prolactin. Correction of these hormones may not necessarily restore libido. The use of testosterance (NPT ) have found abnormal Valsalva ratios that correlate to significant abnormalities in NPT and one injections have shown only a small and variable response in erectile function [19, 20] . Using clomiphene decrease in intercourse frequency [12] .
ESRD results in an acceleration of atherosclerosis in uraemic males may correct the androgen deficiency and increase the sense of well-being, libido, and and may lead to vasculogenic erectile dysfunction by occluding large vessels and their arterial tributaries potency, similarly to testosterone administration; however, its long-term use in uraemia is inconclusive [21] . [13] . Large proportions of patients with ESRD (78%) were found to have significant cavernosal artery occlus-In patients with increased prolactin levels, both druginduced hyperprolactinaemia and pituitary adenomas ive disease, resulting in erectile dysfunction [14] . Other arterial risk factors such as hypertension, hyperlipid-should be excluded. Drugs that induce hyperprolactinaemia include dopamine receptor antagonists such as aemia, and smoking, on their own seem to be less important factors in causing penile atherosclerosis [15] . phenothiazine, chlorpromazine, promazine, haloperidol, metoclopramide, and CNS dopamine depleting Several drugs are implicated (diuretics, beta-blockers) but substitution with other agents frequently does not agents such as methyldopa and reserpine, and also oestrogen in high doses. Dopamine receptor agonists result in any improvement in sexual dysfunction. Altered erythropoietin synthesis in ESRD leads to such as bromocriptine and lisurude hydrochloride can be used. To treat erectile dysfunction, bromocriptine anaemia with low oxygen delivery to the corpora cavernosa. This has been shown to decrease nitric in doses of 2.5-5 mg has been shown to improve libido and potency; the mechanism, however, remains unclear oxide synthesis and increase endothelium-derived contracting factors, resulting in increased smooth-muscle and it is possible that bromocriptine may influence potency directly as a result of its dopaminergic tone and inhibiting erection [16, 17] . Finally, urinary metabolites that are nitric oxide synthase inhibitors properties [22] .
Lisuride hydrochloride has a similar effect but with are found in high concentrations in ESRD patients, and contribute further to erectile dysfunction.
few reported side-effects [23] . If there is no benefit from supplementation with these agents, further treatPatients with ESRD suffer from chronic fatigue, anxiety and a decline in self-esteem; not surprisingly ment options should be discussed with the patient. An algorithm of management is given in Figure 1 . Several these factors result in lack of sexual interest. Bancroft [10] has probably comes closest in explaining the categories of treatment are available. sexual response cycle, which depends on emotional, cognitive, and genital components, and failure in any of these areas may lead to sexual difficulties.
Oral

Assessment of sexual dysfunction
Sildenafil (Viagra)
The first of possibly many phosphodiestrase The problem of sexual dysfunction should ideally be 5-inhibitors was launched in the USA in 1998. It managed in a dedicated clinic. Precise investigations produces an erection in approximately 60-80% of will depend on history and examination findings. There patients with erectile dysfunction approximately an have been recent developments such as waking erectile hour after taking the drug. Sildenafil acts by inhibiting assessment that objectively assess psychophysiological the conversion of active cGMP to inactive non-cyclic criteria for evaluation of erectile dysfunction [18] .
GMP. Active cGMP relaxes the arteriolar smooth muscles, causing vasodilatation in the corpora cavManagement ernosa and so initiating and maintaining erection. Sildenafil is metabolized by cytochrome P450 and is excreted as active and inactive metabolite in the faeces. Treatment must start with determining and treating
In the original study of its efficacy and safety, patients the underlying causes. Honest evaluation of alcohol, with renal failure were excluded [24] . The rates of tobacco, and recreational drugs is essential. Assessment myocardial infarction and other serious cardiovascular of emotional life, i.e. how well the patient gets along events were not significantly greater than in those with his partner is vital. He may benefit from a referral subjects on placebo. However, since its launch in the to a psychotherapist, or the couple may be advised to USA the food and drug administration ( FDA) have seek marriage guidance. For men in whom vascular received 69 reports of deaths in patients whilst on problem appears to predominate: Doppler studies, Sildenafil. No cases of priapism were reported in any pharmacocavernosometry, pharmacocavernosograof the 28 trials but at least six cases were reported to phy, dynamic infusion studies, and colour Doppler the FDA and there may be a real danger of penile response studies may be helpful. Once erectile dysfuncmuscle damage and fibrosis [25] . Use of Sildenafil in tion is diagnosed and psychosexual component is ruled dialysis patients has shown significant improvement in out a review of the drugs, haemoglobulin levels and erectile dysfunction in two small studies [26, 27] . The dialysis adequacy should be corrected. They should have hormonal studies, including testosterone, LH, major side-effect reported was headache although with End-stage renal disease and erectile dysfunction 1527 Oral phentolamine, a short-acting alpha-blocker, is not yet licensed for use in erectile impotence. Sublingual apomorphine, a potent stimulator of D1 and D2 receptors, is also not licensed. Phosphodiestrase 5-inhibitor in the form of nasal spray is soon to be marketed. Minoxidil (topical to the glans penis) in one trial was found to increase both diameter and rigidity of the penis [32] . Condoms are recommended if minoxidil cream is used, to protect the partner. This again has not been studied in CRF patients.
Intraurethral
Alprostadil (prostaglandin E1)
This provides transurethral delivery of prostaglandin to the corpus cavernosum. The medication is put in an applicator that is inserted in the urethra. Depressing the button on the applicator releases the medicated pellet. It is sold under the brand name of MUSE (Medicated Urethral System for Erection). In a large study of 1511 men with organic erectile dysfunction, the success rate was about 70% [33] . Penile pain was reported in 35.7% of the men and caused 2.4% of them to discontinue the study.
Intracavernosal
Alprostadil (prostaglandin E1)
Alprostadil is injected into the shaft of the penis (Caverject). It causes smooth-muscle relaxation, vasodilatation, and inhibition of platelet aggregation. Patient and partner satisfaction is reported as 80-85%. Side-effects are mainly local and include pain (17%), haematoma or ecchymosis (1.5%) and priapism (1.3%). Patients with ESRD have a coagulopathy, which is greater in those on haemodialysis; therefore intracaver- nosal injections should be used with caution.
Vacuum devices the high incidence of cardiovascular disease in patients with ESRD we need larger studies to assess safety.
Vacuum constriction devices and constriction bands have been used for many years and have been reported as effective in patients with erectile dysfunction. A Yohimbine hydrochloride cylinder is placed over the penis and the air is withThis is an indole alkaloid derivative initially from the drawn, creating a negative pressure, which is filled by bark of the yohimbine tree and has long been consid-an increase in blood flow into the penis, resulting in ered an aphrodisiac [28] . Initial studies reported excel-an erection. A tension ring is than placed on the base lent results in 80% of the patients [29] . Subsequent on the erect penis to maintain rigidity. This can be left studies have not substantiated its efficacy [30] . The use in place for up to 30 min. This is effective with success of Yohimbine in renal failure has not been studied.
rates of up to 90%. Side-effects include local pain, numbness of the penis, a cold, dusky penis, and local Other drugs irritation.
The treatment of anaemia with recombinant human Penile prostheses erythropoietin in male renal failure patients has been reported to improve the sexual performance [31] . This These procedures should await renal transplantation, since many of the men may improve their sexual has been attributed either to an increase in general well-being or to a normalization of sex hormones. function after transplantation. Testosterone levels return to normal range within 2-3 months and this This, however, remains controversial. Using erythropoietin as a primary treatment would be inappropriate. parallels LH, FSH, and prolactin normalization [34] .
system dysfunction and impotence in uremia. Am J Nephrol
It is important to remember that, post-transplant, 87% 
